{
  "solution_stats": {
    "total_solutions": 12,
    "details": [
      {
        "solution_id": 1,
        "steps_count": 5
      },
      {
        "solution_id": 2,
        "steps_count": 5
      },
      {
        "solution_id": 3,
        "steps_count": 5
      },
      {
        "solution_id": 4,
        "steps_count": 6
      },
      {
        "solution_id": 5,
        "steps_count": 9
      },
      {
        "solution_id": 6,
        "steps_count": 5
      },
      {
        "solution_id": 7,
        "steps_count": 5
      },
      {
        "solution_id": 8,
        "steps_count": 7
      },
      {
        "solution_id": 9,
        "steps_count": 8
      },
      {
        "solution_id": 10,
        "steps_count": 7
      },
      {
        "solution_id": 11,
        "steps_count": 6
      },
      {
        "solution_id": 12,
        "steps_count": 8
      }
    ]
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule60",
              "prover9": "(-(A4 -> A5) -> A6)",
              "prover9_expression": "(-(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x)) -> clinical_trial_failed(drug_x))",
              "natural": "Provided that it is not the case that if drug X requires a clinical trial, then the clinical trial for drug X is completed, then the clinical trial for drug X has failed."
            },
            {
              "id": "Rule61",
              "prover9": "(-(A4 -> A5) -> -A6)",
              "prover9_expression": "(-(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x)) -> -clinical_trial_failed(drug_x))",
              "natural": "In the event that it is not the case that if drug X requires a clinical trial, then the clinical trial for drug X is completed, then it is not the case that the clinical trial for drug X has failed."
            }
          ],
          "conclusion": "(A4 -> A5)",
          "natural": "If drug X requires a clinical trial, then the clinical trial for drug X is completed."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A4 -> A5)",
              "prover9_expression": "(requires_clinical_trial(drug_x) -> clinical_trial_completed(drug_x))",
              "natural": "If drug X requires a clinical trial, then the clinical trial for drug X is completed."
            },
            {
              "id": "Fact7",
              "prover9": "-A5",
              "prover9_expression": "-clinical_trial_completed(drug_x)",
              "natural": "It is not the case that the clinical trial for drug X is completed."
            }
          ],
          "conclusion": "-A4",
          "natural": "It is not the case that drug X requires a clinical trial."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule57",
              "prover9": "(-(A2 -> -A1) -> A4)",
              "prover9_expression": "(-(rejected(drug_x) -> -approved(drug_x)) -> requires_clinical_trial(drug_x))",
              "natural": "If it is not the case that if drug X is rejected, then it is not the case that drug X is approved, then drug X requires a clinical trial."
            },
            {
              "id": "Derived",
              "prover9": "-A4",
              "prover9_expression": "-requires_clinical_trial(drug_x)",
              "natural": "It is not the case that drug X requires a clinical trial."
            }
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "If drug X is rejected, then it is not the case that drug X is approved."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule10",
              "prover9": "(A2 | A3)",
              "prover9_expression": "(rejected(drug_x) | pending_review(drug_x))",
              "natural": "Either drug X is rejected, or drug X is pending review."
            },
            {
              "id": "Derived",
              "prover9": "(A2 -> -A1)",
              "prover9_expression": "(rejected(drug_x) -> -approved(drug_x))",
              "natural": "If drug X is rejected, then it is not the case that drug X is approved."
            },
            {
              "id": "Rule21",
              "prover9": "(A3 -> -A1)",
              "prover9_expression": "(pending_review(drug_x) -> -approved(drug_x))",
              "natural": "Should drug X be pending review, then it is not the case that drug X is approved."
            }
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule68",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-safe_for_use(drug_x) -> approved(drug_x))",
              "natural": "If it is not the case that drug X is safe for use, then drug X is approved."
            },
            {
              "id": "Derived",
              "prover9": "-A1",
              "prover9_expression": "-approved(drug_x)",
              "natural": "It is not the case that drug X is approved."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule2",
              "prover9": "(A12 | (-(A9 -> G) -> A11))",
              "prover9_expression": "(fast_track_approval(drug_x) | (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_black_box_warning(drug_x)))",
              "natural": "Either drug X receives fast track approval, or if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a black box warning."
            },
            {
              "id": "Fact3",
              "prover9": "-A12",
              "prover9_expression": "-fast_track_approval(drug_x)",
              "natural": "It is not the case that drug X receives fast track approval."
            }
          ],
          "conclusion": "(-(A9 -> G) -> A11)",
          "natural": "Provided that the absence of mild side effects does not imply drug X is safe for use, then drug X requires a black box warning."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A9 -> G) -> A11)",
              "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_black_box_warning(drug_x))",
              "natural": "Provided that the absence of mild side effects does not imply drug X is safe for use, then drug X requires a black box warning."
            },
            {
              "id": "Rule1",
              "prover9": "(A11 -> A10)",
              "prover9_expression": "(requires_black_box_warning(drug_x) -> requires_warning_label(drug_x))",
              "natural": "If drug X requires a black box warning, then drug X requires a warning label."
            }
          ],
          "conclusion": "(-(A9 -> G) -> A10)",
          "natural": "If the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A9 -> G) -> A10)",
              "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))",
              "natural": "If the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label."
            },
            {
              "id": "Rule64",
              "prover9": "(-(A9 -> G) -> -A10)",
              "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> -requires_warning_label(drug_x))",
              "natural": "If the absence of mild side effects does not imply drug X is safe for use, then it is not the case that drug X requires a warning label."
            }
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If drug X has mild side effects, then drug X is safe for use."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule55",
              "prover9": "(A8 -> A7)",
              "prover9_expression": "(severe_side_effects(drug_x) -> has_side_effects(drug_x))",
              "natural": "Provided that drug X has severe side effects, then drug X has side effects."
            },
            {
              "id": "Derived",
              "prover9": "(A9 -> G)",
              "prover9_expression": "(mild_side_effects(drug_x) -> safe_for_use(drug_x))",
              "natural": "If drug X has mild side effects, then drug X is safe for use."
            },
            {
              "id": "Rule56",
              "prover9": "(A8 | A9)",
              "prover9_expression": "(severe_side_effects(drug_x) | mild_side_effects(drug_x))",
              "natural": "Drug X has severe side effects, or drug X has mild side effects."
            }
          ],
          "conclusion": "(A7 | G)",
          "natural": "Either drug X has side effects, or drug X is safe for use."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A7 | G)",
              "prover9_expression": "(has_side_effects(drug_x) | safe_for_use(drug_x))",
              "natural": "Either drug X has side effects, or drug X is safe for use."
            },
            {
              "id": "Fact11",
              "prover9": "-A7",
              "prover9_expression": "-has_side_effects(drug_x)",
              "natural": "It is not the case that drug X has side effects."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule11",
              "prover9": "(A20 | -A19)",
              "prover9_expression": "(voluntary_recall(drug_x) | -market_withdrawal(drug_x))",
              "natural": "Drug X is voluntarily recalled, or it is not the case that drug X is withdrawn from the market."
            },
            {
              "id": "Fact4",
              "prover9": "-A20",
              "prover9_expression": "-voluntary_recall(drug_x)",
              "natural": "It is not the case that drug X is voluntarily recalled."
            }
          ],
          "conclusion": "-A19",
          "natural": "It is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule9",
              "prover9": "(A19 | (A17 | A18))",
              "prover9_expression": "(market_withdrawal(drug_x) | (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
              "natural": "Drug X is withdrawn from the market, or a safety profile for drug X is established, or efficacy of drug X is demonstrated."
            },
            {
              "id": "Derived",
              "prover9": "-A19",
              "prover9_expression": "-market_withdrawal(drug_x)",
              "natural": "It is not the case that drug X is withdrawn from the market."
            }
          ],
          "conclusion": "(A17 | A18)",
          "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A17 | A18)",
              "prover9_expression": "(safety_profile_established(drug_x) | efficacy_demonstrated(drug_x))",
              "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
            },
            {
              "id": "Rule7",
              "prover9": "(A17 -> (A15 | A16))",
              "prover9_expression": "(safety_profile_established(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
              "natural": "Should a safety profile for drug X be established, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
            },
            {
              "id": "Rule8",
              "prover9": "(A18 -> (A15 | A16))",
              "prover9_expression": "(efficacy_demonstrated(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
              "natural": "Assuming efficacy of drug X is demonstrated, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
            }
          ],
          "conclusion": "(A15 | A16)",
          "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule5",
              "prover9": "(A15 -> A13)",
              "prover9_expression": "(animal_testing_complete(drug_x) -> phase1_complete(drug_x))",
              "natural": "If animal testing for drug X is complete, then phase 1 for drug X is complete."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A14)",
              "prover9_expression": "(preliminary_human_trials_complete(drug_x) -> phase2_complete(drug_x))",
              "natural": "In the event that preliminary human trials for drug X are complete, phase 2 for drug X is complete."
            },
            {
              "id": "Derived",
              "prover9": "(A15 | A16)",
              "prover9_expression": "(animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x))",
              "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
            }
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(phase1_complete(drug_x) | phase2_complete(drug_x))",
              "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
            },
            {
              "id": "Rule3",
              "prover9": "(A13 -> G)",
              "prover9_expression": "(phase1_complete(drug_x) -> safe_for_use(drug_x))",
              "natural": "Provided that phase 1 for drug X is complete, drug X is safe for use."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> G)",
              "prover9_expression": "(phase2_complete(drug_x) -> safe_for_use(drug_x))",
              "natural": "Whenever phase 2 for drug X is complete, drug X is safe for use."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule13",
              "prover9": "(A21 -> A24)",
              "prover9_expression": "(regulatory_violation(drug_x) -> criminal_charges(drug_x))",
              "natural": "Whenever drug X has a regulatory violation, criminal charges are filed for drug X."
            },
            {
              "id": "Rule16",
              "prover9": "(A24 -> A23)",
              "prover9_expression": "(criminal_charges(drug_x) -> license_suspended(drug_x))",
              "natural": "If criminal charges are filed for drug X, then the license for drug X is suspended."
            }
          ],
          "conclusion": "(A21 -> A23)",
          "natural": "If drug X has a regulatory violation, then the license for drug X is suspended."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A21 -> A23)",
              "prover9_expression": "(regulatory_violation(drug_x) -> license_suspended(drug_x))",
              "natural": "If drug X has a regulatory violation, then the license for drug X is suspended."
            },
            {
              "id": "Rule15",
              "prover9": "(A23 -> -A22)",
              "prover9_expression": "(license_suspended(drug_x) -> -fine_imposed(drug_x))",
              "natural": "Should the license for drug X be suspended, then it is not the case that a fine is imposed on drug X."
            }
          ],
          "conclusion": "(A21 -> -A22)",
          "natural": "In case drug X has a regulatory violation, then it is not the case that a fine is imposed on drug X."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule12",
              "prover9": "(A21 -> A22)",
              "prover9_expression": "(regulatory_violation(drug_x) -> fine_imposed(drug_x))",
              "natural": "Provided that drug X has a regulatory violation, a fine is imposed on drug X."
            },
            {
              "id": "Derived",
              "prover9": "(A21 -> -A22)",
              "prover9_expression": "(regulatory_violation(drug_x) -> -fine_imposed(drug_x))",
              "natural": "In case drug X has a regulatory violation, then it is not the case that a fine is imposed on drug X."
            }
          ],
          "conclusion": "-A21",
          "natural": "It is not the case that drug X has a regulatory violation."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule14",
              "prover9": "(A21 | (A2 -> -A1))",
              "prover9_expression": "(regulatory_violation(drug_x) | (rejected(drug_x) -> -approved(drug_x)))",
              "natural": "Drug X has a regulatory violation, or if drug X is rejected, then it is not the case that drug X is approved."
            },
            {
              "id": "Derived",
              "prover9": "-A21",
              "prover9_expression": "-regulatory_violation(drug_x)",
              "natural": "It is not the case that drug X has a regulatory violation."
            }
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "If drug X is rejected, then it is not the case that drug X is approved."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule10",
              "prover9": "(A2 | A3)",
              "prover9_expression": "(rejected(drug_x) | pending_review(drug_x))",
              "natural": "Either drug X is rejected, or drug X is pending review."
            },
            {
              "id": "Derived",
              "prover9": "(A2 -> -A1)",
              "prover9_expression": "(rejected(drug_x) -> -approved(drug_x))",
              "natural": "If drug X is rejected, then it is not the case that drug X is approved."
            },
            {
              "id": "Rule21",
              "prover9": "(A3 -> -A1)",
              "prover9_expression": "(pending_review(drug_x) -> -approved(drug_x))",
              "natural": "Should drug X be pending review, then it is not the case that drug X is approved."
            }
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule68",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-safe_for_use(drug_x) -> approved(drug_x))",
              "natural": "If it is not the case that drug X is safe for use, then drug X is approved."
            },
            {
              "id": "Derived",
              "prover9": "-A1",
              "prover9_expression": "-approved(drug_x)",
              "natural": "It is not the case that drug X is approved."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule58",
              "prover9": "(-(A34 -> (A30 | A31)) -> A35)",
              "prover9_expression": "(-(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))) -> profitability_decline(drug_x))",
              "natural": "Should it not be the case that if drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted, then profitability of drug X declines."
            },
            {
              "id": "Rule59",
              "prover9": "(-(A34 -> (A30 | A31)) -> -A35)",
              "prover9_expression": "(-(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))) -> -profitability_decline(drug_x))",
              "natural": "If it is not the case that if drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted, then it is not the case that profitability of drug X declines."
            }
          ],
          "conclusion": "(A34 -> (A30 | A31))",
          "natural": "Assuming drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule24",
              "prover9": "(A33 -> A32)",
              "prover9_expression": "(price_reduction(drug_x) -> competitive_market_entry(drug_x))",
              "natural": "Whenever the price of drug X is reduced, competitive market entry occurs for drug X."
            },
            {
              "id": "Derived",
              "prover9": "(A34 -> (A30 | A31))",
              "prover9_expression": "(market_share_loss(drug_x) -> (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x)))",
              "natural": "Assuming drug X experiences market share loss, then either a generic application for drug X is submitted or a biosimilar application for drug X is submitted."
            },
            {
              "id": "Rule25",
              "prover9": "(A33 | A34)",
              "prover9_expression": "(price_reduction(drug_x) | market_share_loss(drug_x))",
              "natural": "The price of drug X is reduced, or drug X experiences market share loss."
            }
          ],
          "conclusion": "(A32 | (A30 | A31))",
          "natural": "Competitive market entry occurs for drug X, or a generic application for drug X is submitted, or a biosimilar application for drug X is submitted."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A32 | (A30 | A31))",
              "prover9_expression": "(competitive_market_entry(drug_x) | (generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x)))",
              "natural": "Competitive market entry occurs for drug X, or a generic application for drug X is submitted, or a biosimilar application for drug X is submitted."
            },
            {
              "id": "Fact5",
              "prover9": "-A32",
              "prover9_expression": "-competitive_market_entry(drug_x)",
              "natural": "It is not the case that competitive market entry occurs for drug X."
            }
          ],
          "conclusion": "(A30 | A31)",
          "natural": "Either a generic application for drug X is submitted, or a biosimilar application for drug X is submitted."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule22",
              "prover9": "(A30 -> A28)",
              "prover9_expression": "(generic_application_submitted(drug_x) -> patent_expired(drug_x))",
              "natural": "If a generic application for drug X is submitted, then the patent for drug X has expired."
            },
            {
              "id": "Rule23",
              "prover9": "(A31 -> A29)",
              "prover9_expression": "(biosimilar_application_submitted(drug_x) -> patent_challenged(drug_x))",
              "natural": "Provided that a biosimilar application for drug X is submitted, then the patent for drug X is challenged."
            },
            {
              "id": "Derived",
              "prover9": "(A30 | A31)",
              "prover9_expression": "(generic_application_submitted(drug_x) | biosimilar_application_submitted(drug_x))",
              "natural": "Either a generic application for drug X is submitted, or a biosimilar application for drug X is submitted."
            }
          ],
          "conclusion": "(A28 | A29)",
          "natural": "Either the patent for drug X has expired, or the patent for drug X is challenged."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A28 | A29)",
              "prover9_expression": "(patent_expired(drug_x) | patent_challenged(drug_x))",
              "natural": "Either the patent for drug X has expired, or the patent for drug X is challenged."
            },
            {
              "id": "Rule19",
              "prover9": "(A28 -> (-A25 -> A27))",
              "prover9_expression": "(patent_expired(drug_x) -> (-patent_protected(drug_x) -> exclusive_marketing(drug_x)))",
              "natural": "If the patent for drug X has expired, then if it is not the case that drug X is patent protected, drug X has exclusive marketing rights."
            },
            {
              "id": "Rule20",
              "prover9": "(A29 -> (-A25 -> A27))",
              "prover9_expression": "(patent_challenged(drug_x) -> (-patent_protected(drug_x) -> exclusive_marketing(drug_x)))",
              "natural": "In the event that the patent for drug X is challenged, then if it is not the case that drug X is patent protected, drug X has exclusive marketing rights."
            }
          ],
          "conclusion": "(-A25 -> A27)",
          "natural": "If it is not the case that drug X is patent protected, then drug X has exclusive marketing rights."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-A25 -> A27)",
              "prover9_expression": "(-patent_protected(drug_x) -> exclusive_marketing(drug_x))",
              "natural": "If it is not the case that drug X is patent protected, then drug X has exclusive marketing rights."
            },
            {
              "id": "Rule18",
              "prover9": "(A27 -> -A26)",
              "prover9_expression": "(exclusive_marketing(drug_x) -> -generic_available(drug_x))",
              "natural": "Provided that drug X has exclusive marketing rights, then it is not the case that a generic version of drug X is available."
            }
          ],
          "conclusion": "(-A25 -> -A26)",
          "natural": "Provided that it is not the case that drug X is patent protected, then it is not the case that a generic version of drug X is available."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule66",
              "prover9": "(-A25 -> A26)",
              "prover9_expression": "(-patent_protected(drug_x) -> generic_available(drug_x))",
              "natural": "Should it not be the case that drug X is patent protected, then a generic version of drug X is available."
            },
            {
              "id": "Derived",
              "prover9": "(-A25 -> -A26)",
              "prover9_expression": "(-patent_protected(drug_x) -> -generic_available(drug_x))",
              "natural": "Provided that it is not the case that drug X is patent protected, then it is not the case that a generic version of drug X is available."
            }
          ],
          "conclusion": "A25",
          "natural": "Drug X is patent protected."
        },
        {
          "step_number": 8,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule17",
              "prover9": "(A25 -> -A1)",
              "prover9_expression": "(patent_protected(drug_x) -> -approved(drug_x))",
              "natural": "Assuming drug X is patent protected, then it is not the case that drug X is approved."
            },
            {
              "id": "Derived",
              "prover9": "A25",
              "prover9_expression": "patent_protected(drug_x)",
              "natural": "Drug X is patent protected."
            }
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 9,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule68",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-safe_for_use(drug_x) -> approved(drug_x))",
              "natural": "If it is not the case that drug X is safe for use, then drug X is approved."
            },
            {
              "id": "Derived",
              "prover9": "-A1",
              "prover9_expression": "-approved(drug_x)",
              "natural": "It is not the case that drug X is approved."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule28",
              "prover9": "(A37 | A38)",
              "prover9_expression": "(rare_disease_indication(drug_x) | unmet_medical_need(drug_x))",
              "natural": "Either drug X has a rare disease indication, or drug X addresses an unmet medical need."
            },
            {
              "id": "Rule27",
              "prover9": "(A37 -> -A36)",
              "prover9_expression": "(rare_disease_indication(drug_x) -> -orphan_drug_status(drug_x))",
              "natural": "If drug X has a rare disease indication, then it is not the case that drug X has orphan drug status."
            },
            {
              "id": "Rule29",
              "prover9": "(A38 -> -A36)",
              "prover9_expression": "(unmet_medical_need(drug_x) -> -orphan_drug_status(drug_x))",
              "natural": "In case drug X addresses an unmet medical need, then it is not the case that drug X has orphan drug status."
            }
          ],
          "conclusion": "-A36",
          "natural": "It is not the case that drug X has orphan drug status."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule26",
              "prover9": "(A36 | -A4)",
              "prover9_expression": "(orphan_drug_status(drug_x) | -requires_clinical_trial(drug_x))",
              "natural": "Drug X has orphan drug status, or it is not the case that drug X requires a clinical trial."
            },
            {
              "id": "Derived",
              "prover9": "-A36",
              "prover9_expression": "-orphan_drug_status(drug_x)",
              "natural": "It is not the case that drug X has orphan drug status."
            }
          ],
          "conclusion": "-A4",
          "natural": "It is not the case that drug X requires a clinical trial."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule57",
              "prover9": "(-(A2 -> -A1) -> A4)",
              "prover9_expression": "(-(rejected(drug_x) -> -approved(drug_x)) -> requires_clinical_trial(drug_x))",
              "natural": "If it is not the case that if drug X is rejected, then it is not the case that drug X is approved, then drug X requires a clinical trial."
            },
            {
              "id": "Derived",
              "prover9": "-A4",
              "prover9_expression": "-requires_clinical_trial(drug_x)",
              "natural": "It is not the case that drug X requires a clinical trial."
            }
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "If drug X is rejected, then it is not the case that drug X is approved."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule10",
              "prover9": "(A2 | A3)",
              "prover9_expression": "(rejected(drug_x) | pending_review(drug_x))",
              "natural": "Either drug X is rejected, or drug X is pending review."
            },
            {
              "id": "Derived",
              "prover9": "(A2 -> -A1)",
              "prover9_expression": "(rejected(drug_x) -> -approved(drug_x))",
              "natural": "If drug X is rejected, then it is not the case that drug X is approved."
            },
            {
              "id": "Rule21",
              "prover9": "(A3 -> -A1)",
              "prover9_expression": "(pending_review(drug_x) -> -approved(drug_x))",
              "natural": "Should drug X be pending review, then it is not the case that drug X is approved."
            }
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule68",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-safe_for_use(drug_x) -> approved(drug_x))",
              "natural": "If it is not the case that drug X is safe for use, then drug X is approved."
            },
            {
              "id": "Derived",
              "prover9": "-A1",
              "prover9_expression": "-approved(drug_x)",
              "natural": "It is not the case that drug X is approved."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule62",
              "prover9": "(-(A41 -> (A9 -> A39)) -> A42)",
              "prover9_expression": "(-(risk_management_program(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x))) -> safety_concerns(drug_x))",
              "natural": "Assuming it is not the case that if drug X has a risk management program, then if drug X has mild side effects, drug X requires monitoring, then there are safety concerns for drug X."
            },
            {
              "id": "Fact6",
              "prover9": "-A42",
              "prover9_expression": "-safety_concerns(drug_x)",
              "natural": "It is not the case that there are safety concerns for drug X."
            }
          ],
          "conclusion": "(A41 -> (A9 -> A39))",
          "natural": "In the event that drug X has a risk management program, then if drug X has mild side effects, drug X requires monitoring."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule32",
              "prover9": "(A40 | A41)",
              "prover9_expression": "(post_market_surveillance(drug_x) | risk_management_program(drug_x))",
              "natural": "Drug X is under post-market surveillance, or drug X has a risk management program."
            },
            {
              "id": "Rule31",
              "prover9": "(A40 -> (A9 -> A39))",
              "prover9_expression": "(post_market_surveillance(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x)))",
              "natural": "Should drug X be under post-market surveillance, then if drug X has mild side effects, drug X requires monitoring."
            },
            {
              "id": "Derived",
              "prover9": "(A41 -> (A9 -> A39))",
              "prover9_expression": "(risk_management_program(drug_x) -> (mild_side_effects(drug_x) -> requires_monitoring(drug_x)))",
              "natural": "In the event that drug X has a risk management program, then if drug X has mild side effects, drug X requires monitoring."
            }
          ],
          "conclusion": "(A9 -> A39)",
          "natural": "Assuming drug X has mild side effects, then drug X requires monitoring."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A9 -> A39)",
              "prover9_expression": "(mild_side_effects(drug_x) -> requires_monitoring(drug_x))",
              "natural": "Assuming drug X has mild side effects, then drug X requires monitoring."
            },
            {
              "id": "Rule30",
              "prover9": "(A39 -> G)",
              "prover9_expression": "(requires_monitoring(drug_x) -> safe_for_use(drug_x))",
              "natural": "Provided that drug X requires monitoring, then drug X is safe for use."
            }
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If drug X has mild side effects, then drug X is safe for use."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule55",
              "prover9": "(A8 -> A7)",
              "prover9_expression": "(severe_side_effects(drug_x) -> has_side_effects(drug_x))",
              "natural": "Provided that drug X has severe side effects, then drug X has side effects."
            },
            {
              "id": "Derived",
              "prover9": "(A9 -> G)",
              "prover9_expression": "(mild_side_effects(drug_x) -> safe_for_use(drug_x))",
              "natural": "If drug X has mild side effects, then drug X is safe for use."
            },
            {
              "id": "Rule56",
              "prover9": "(A8 | A9)",
              "prover9_expression": "(severe_side_effects(drug_x) | mild_side_effects(drug_x))",
              "natural": "Drug X has severe side effects, or drug X has mild side effects."
            }
          ],
          "conclusion": "(A7 | G)",
          "natural": "Either drug X has side effects, or drug X is safe for use."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A7 | G)",
              "prover9_expression": "(has_side_effects(drug_x) | safe_for_use(drug_x))",
              "natural": "Either drug X has side effects, or drug X is safe for use."
            },
            {
              "id": "Fact11",
              "prover9": "-A7",
              "prover9_expression": "-has_side_effects(drug_x)",
              "natural": "It is not the case that drug X has side effects."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule37",
              "prover9": "(A48 -> (A46 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45)))",
              "prover9_expression": "(compliance_certified(drug_x) -> (audit_scheduled(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x))))",
              "natural": "Should drug X be compliance certified, then if an audit is scheduled for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
            },
            {
              "id": "Fact1",
              "prover9": "A48",
              "prover9_expression": "compliance_certified(drug_x)",
              "natural": "Drug X is compliance certified."
            }
          ],
          "conclusion": "(A46 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45))",
          "natural": "If an audit is scheduled for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule35",
              "prover9": "(A46 | A47)",
              "prover9_expression": "(audit_scheduled(drug_x) | inspection_required(drug_x))",
              "natural": "Either an audit is scheduled for drug X, or an inspection is required for drug X."
            },
            {
              "id": "Derived",
              "prover9": "(A46 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45))",
              "prover9_expression": "(audit_scheduled(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x)))",
              "natural": "If an audit is scheduled for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
            },
            {
              "id": "Rule36",
              "prover9": "(A47 -> (-(A44 -> (-(A9 -> G) -> A10)) -> A45))",
              "prover9_expression": "(inspection_required(drug_x) -> (-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x)))",
              "natural": "Whenever an inspection is required for drug X, then if it is not the case that a patient registry exists for drug X implies that if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
            }
          ],
          "conclusion": "(-(A44 -> (-(A9 -> G) -> A10)) -> A45)",
          "natural": "If it is not the case that if a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A44 -> (-(A9 -> G) -> A10)) -> A45)",
              "prover9_expression": "(-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> data_integrity_issue(drug_x))",
              "natural": "If it is not the case that if a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then drug X has a data integrity issue."
            },
            {
              "id": "Rule63",
              "prover9": "(-(A44 -> (-(A9 -> G) -> A10)) -> -A45)",
              "prover9_expression": "(-(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))) -> -data_integrity_issue(drug_x))",
              "natural": "Should it not be the case that if a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label, then it is not the case that drug X has a data integrity issue."
            }
          ],
          "conclusion": "(A44 -> (-(A9 -> G) -> A10))",
          "natural": "Provided that a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires a warning label."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule34",
              "prover9": "(A43 | A44)",
              "prover9_expression": "(adverse_event_reporting(drug_x) | patient_registry(drug_x))",
              "natural": "Adverse event reporting is conducted for drug X, or a patient registry exists for drug X."
            },
            {
              "id": "Rule33",
              "prover9": "(A43 -> (-(A9 -> G) -> A10))",
              "prover9_expression": "(adverse_event_reporting(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x)))",
              "natural": "Assuming adverse event reporting is conducted for drug X, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires a warning label."
            },
            {
              "id": "Derived",
              "prover9": "(A44 -> (-(A9 -> G) -> A10))",
              "prover9_expression": "(patient_registry(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x)))",
              "natural": "Provided that a patient registry exists for drug X, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires a warning label."
            }
          ],
          "conclusion": "(-(A9 -> G) -> A10)",
          "natural": "If the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A9 -> G) -> A10)",
              "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> requires_warning_label(drug_x))",
              "natural": "If the absence of mild side effects does not imply drug X is safe for use, then drug X requires a warning label."
            },
            {
              "id": "Rule64",
              "prover9": "(-(A9 -> G) -> -A10)",
              "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> -requires_warning_label(drug_x))",
              "natural": "If the absence of mild side effects does not imply drug X is safe for use, then it is not the case that drug X requires a warning label."
            }
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If drug X has mild side effects, then drug X is safe for use."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule55",
              "prover9": "(A8 -> A7)",
              "prover9_expression": "(severe_side_effects(drug_x) -> has_side_effects(drug_x))",
              "natural": "Provided that drug X has severe side effects, then drug X has side effects."
            },
            {
              "id": "Derived",
              "prover9": "(A9 -> G)",
              "prover9_expression": "(mild_side_effects(drug_x) -> safe_for_use(drug_x))",
              "natural": "If drug X has mild side effects, then drug X is safe for use."
            },
            {
              "id": "Rule56",
              "prover9": "(A8 | A9)",
              "prover9_expression": "(severe_side_effects(drug_x) | mild_side_effects(drug_x))",
              "natural": "Drug X has severe side effects, or drug X has mild side effects."
            }
          ],
          "conclusion": "(A7 | G)",
          "natural": "Either drug X has side effects, or drug X is safe for use."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A7 | G)",
              "prover9_expression": "(has_side_effects(drug_x) | safe_for_use(drug_x))",
              "natural": "Either drug X has side effects, or drug X is safe for use."
            },
            {
              "id": "Fact11",
              "prover9": "-A7",
              "prover9_expression": "-has_side_effects(drug_x)",
              "natural": "It is not the case that drug X has side effects."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 9,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule40",
              "prover9": "(A52 -> A54)",
              "prover9_expression": "(prescription_required(drug_x) -> specialist_referral(drug_x))",
              "natural": "If a prescription is required for drug X, then a specialist referral is required for drug X."
            },
            {
              "id": "Rule42",
              "prover9": "(A54 -> A53)",
              "prover9_expression": "(specialist_referral(drug_x) -> physician_authorization(drug_x))",
              "natural": "Should a specialist referral be required for drug X, then physician authorization is needed for drug X."
            }
          ],
          "conclusion": "(A52 -> A53)",
          "natural": "Assuming a prescription is required for drug X, then physician authorization is needed for drug X."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A52 -> A53)",
              "prover9_expression": "(prescription_required(drug_x) -> physician_authorization(drug_x))",
              "natural": "Assuming a prescription is required for drug X, then physician authorization is needed for drug X."
            },
            {
              "id": "Rule41",
              "prover9": "(A52 -> -A53)",
              "prover9_expression": "(prescription_required(drug_x) -> -physician_authorization(drug_x))",
              "natural": "In case a prescription is required for drug X, then it is not the case that physician authorization is needed for drug X."
            }
          ],
          "conclusion": "-A52",
          "natural": "It is not the case that a prescription is required for drug X."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule67",
              "prover9": "(-A51 -> A52)",
              "prover9_expression": "(-controlled_substance(drug_x) -> prescription_required(drug_x))",
              "natural": "In the event that it is not the case that drug X is a controlled substance, then a prescription is required for drug X."
            },
            {
              "id": "Derived",
              "prover9": "-A52",
              "prover9_expression": "-prescription_required(drug_x)",
              "natural": "It is not the case that a prescription is required for drug X."
            }
          ],
          "conclusion": "A51",
          "natural": "Drug X is a controlled substance."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule39",
              "prover9": "(A51 -> (-(A9 -> G) -> A50))",
              "prover9_expression": "(controlled_substance(drug_x) -> (-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> special_handling(drug_x)))",
              "natural": "Provided that drug X is a controlled substance, then if the absence of mild side effects does not imply drug X is safe for use, drug X requires special handling."
            },
            {
              "id": "Derived",
              "prover9": "A51",
              "prover9_expression": "controlled_substance(drug_x)",
              "natural": "Drug X is a controlled substance."
            }
          ],
          "conclusion": "(-(A9 -> G) -> A50)",
          "natural": "Whenever the absence of mild side effects does not imply drug X is safe for use, then drug X requires special handling."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A9 -> G) -> A50)",
              "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> special_handling(drug_x))",
              "natural": "Whenever the absence of mild side effects does not imply drug X is safe for use, then drug X requires special handling."
            },
            {
              "id": "Rule38",
              "prover9": "(A50 -> A49)",
              "prover9_expression": "(special_handling(drug_x) -> restricted_distribution(drug_x))",
              "natural": "If drug X requires special handling, then drug X has restricted distribution."
            }
          ],
          "conclusion": "(-(A9 -> G) -> A49)",
          "natural": "In case the absence of mild side effects does not imply drug X is safe for use, then drug X has restricted distribution."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A9 -> G) -> A49)",
              "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> restricted_distribution(drug_x))",
              "natural": "In case the absence of mild side effects does not imply drug X is safe for use, then drug X has restricted distribution."
            },
            {
              "id": "Rule65",
              "prover9": "(-(A9 -> G) -> -A49)",
              "prover9_expression": "(-(mild_side_effects(drug_x) -> safe_for_use(drug_x)) -> -restricted_distribution(drug_x))",
              "natural": "Assuming the absence of mild side effects does not imply drug X is safe for use, then it is not the case that drug X has restricted distribution."
            }
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If drug X has mild side effects, then drug X is safe for use."
        },
        {
          "step_number": 7,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule55",
              "prover9": "(A8 -> A7)",
              "prover9_expression": "(severe_side_effects(drug_x) -> has_side_effects(drug_x))",
              "natural": "Provided that drug X has severe side effects, then drug X has side effects."
            },
            {
              "id": "Derived",
              "prover9": "(A9 -> G)",
              "prover9_expression": "(mild_side_effects(drug_x) -> safe_for_use(drug_x))",
              "natural": "If drug X has mild side effects, then drug X is safe for use."
            },
            {
              "id": "Rule56",
              "prover9": "(A8 | A9)",
              "prover9_expression": "(severe_side_effects(drug_x) | mild_side_effects(drug_x))",
              "natural": "Drug X has severe side effects, or drug X has mild side effects."
            }
          ],
          "conclusion": "(A7 | G)",
          "natural": "Either drug X has side effects, or drug X is safe for use."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A7 | G)",
              "prover9_expression": "(has_side_effects(drug_x) | safe_for_use(drug_x))",
              "natural": "Either drug X has side effects, or drug X is safe for use."
            },
            {
              "id": "Fact11",
              "prover9": "-A7",
              "prover9_expression": "-has_side_effects(drug_x)",
              "natural": "It is not the case that drug X has side effects."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 10,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule43",
              "prover9": "(A56 -> A58)",
              "prover9_expression": "(quality_control_issue(drug_x) -> batch_recall(drug_x))",
              "natural": "If drug X has a quality control issue, then a batch recall is issued for drug X."
            },
            {
              "id": "Rule46",
              "prover9": "(A58 -> (A55 | -A19))",
              "prover9_expression": "(batch_recall(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
              "natural": "In the event that a batch recall is issued for drug X, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
            }
          ],
          "conclusion": "(A56 -> (A55 | -A19))",
          "natural": "Whenever drug X has a quality control issue, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule44",
              "prover9": "(A56 | A57)",
              "prover9_expression": "(quality_control_issue(drug_x) | contamination_risk(drug_x))",
              "natural": "Either drug X has a quality control issue, or drug X has a contamination risk."
            },
            {
              "id": "Derived",
              "prover9": "(A56 -> (A55 | -A19))",
              "prover9_expression": "(quality_control_issue(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
              "natural": "Whenever drug X has a quality control issue, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
            },
            {
              "id": "Rule45",
              "prover9": "(A57 -> (A55 | -A19))",
              "prover9_expression": "(contamination_risk(drug_x) -> (manufacturing_defect(drug_x) | -market_withdrawal(drug_x)))",
              "natural": "Provided that drug X has a contamination risk, then either drug X has a manufacturing defect or it is not the case that drug X is withdrawn from the market."
            }
          ],
          "conclusion": "(A55 | -A19)",
          "natural": "Drug X has a manufacturing defect, or it is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A55 | -A19)",
              "prover9_expression": "(manufacturing_defect(drug_x) | -market_withdrawal(drug_x))",
              "natural": "Drug X has a manufacturing defect, or it is not the case that drug X is withdrawn from the market."
            },
            {
              "id": "Fact8",
              "prover9": "-A55",
              "prover9_expression": "-manufacturing_defect(drug_x)",
              "natural": "It is not the case that drug X has a manufacturing defect."
            }
          ],
          "conclusion": "-A19",
          "natural": "It is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule9",
              "prover9": "(A19 | (A17 | A18))",
              "prover9_expression": "(market_withdrawal(drug_x) | (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
              "natural": "Drug X is withdrawn from the market, or a safety profile for drug X is established, or efficacy of drug X is demonstrated."
            },
            {
              "id": "Derived",
              "prover9": "-A19",
              "prover9_expression": "-market_withdrawal(drug_x)",
              "natural": "It is not the case that drug X is withdrawn from the market."
            }
          ],
          "conclusion": "(A17 | A18)",
          "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A17 | A18)",
              "prover9_expression": "(safety_profile_established(drug_x) | efficacy_demonstrated(drug_x))",
              "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
            },
            {
              "id": "Rule7",
              "prover9": "(A17 -> (A15 | A16))",
              "prover9_expression": "(safety_profile_established(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
              "natural": "Should a safety profile for drug X be established, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
            },
            {
              "id": "Rule8",
              "prover9": "(A18 -> (A15 | A16))",
              "prover9_expression": "(efficacy_demonstrated(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
              "natural": "Assuming efficacy of drug X is demonstrated, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
            }
          ],
          "conclusion": "(A15 | A16)",
          "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule5",
              "prover9": "(A15 -> A13)",
              "prover9_expression": "(animal_testing_complete(drug_x) -> phase1_complete(drug_x))",
              "natural": "If animal testing for drug X is complete, then phase 1 for drug X is complete."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A14)",
              "prover9_expression": "(preliminary_human_trials_complete(drug_x) -> phase2_complete(drug_x))",
              "natural": "In the event that preliminary human trials for drug X are complete, phase 2 for drug X is complete."
            },
            {
              "id": "Derived",
              "prover9": "(A15 | A16)",
              "prover9_expression": "(animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x))",
              "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
            }
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(phase1_complete(drug_x) | phase2_complete(drug_x))",
              "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
            },
            {
              "id": "Rule3",
              "prover9": "(A13 -> G)",
              "prover9_expression": "(phase1_complete(drug_x) -> safe_for_use(drug_x))",
              "natural": "Provided that phase 1 for drug X is complete, drug X is safe for use."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> G)",
              "prover9_expression": "(phase2_complete(drug_x) -> safe_for_use(drug_x))",
              "natural": "Whenever phase 2 for drug X is complete, drug X is safe for use."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 11,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule50",
              "prover9": "(A62 | A63)",
              "prover9_expression": "(manufacturing_audit(drug_x) | process_validation(drug_x))",
              "natural": "A manufacturing audit is conducted for drug X, or process validation is performed for drug X."
            },
            {
              "id": "Rule49",
              "prover9": "(A62 -> (A60 -> A59))",
              "prover9_expression": "(manufacturing_audit(drug_x) -> (production_halt(drug_x) -> supply_shortage(drug_x)))",
              "natural": "If a manufacturing audit is conducted for drug X, then if production of drug X is halted, drug X has a supply shortage."
            },
            {
              "id": "Rule51",
              "prover9": "(A63 -> (A60 -> A59))",
              "prover9_expression": "(process_validation(drug_x) -> (production_halt(drug_x) -> supply_shortage(drug_x)))",
              "natural": "Provided that process validation is performed for drug X, then if production of drug X is halted, drug X has a supply shortage."
            }
          ],
          "conclusion": "(A60 -> A59)",
          "natural": "Assuming production of drug X is halted, then drug X has a supply shortage."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A60 -> A59)",
              "prover9_expression": "(production_halt(drug_x) -> supply_shortage(drug_x))",
              "natural": "Assuming production of drug X is halted, then drug X has a supply shortage."
            },
            {
              "id": "Rule48",
              "prover9": "(A61 -> (A17 | A18))",
              "prover9_expression": "(raw_material_shortage(drug_x) -> (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
              "natural": "Should drug X have a raw material shortage, then either a safety profile for drug X is established or efficacy of drug X is demonstrated."
            },
            {
              "id": "Rule47",
              "prover9": "(A60 | A61)",
              "prover9_expression": "(production_halt(drug_x) | raw_material_shortage(drug_x))",
              "natural": "Either production of drug X is halted, or drug X has a raw material shortage."
            }
          ],
          "conclusion": "(A59 | (A17 | A18))",
          "natural": "Drug X has a supply shortage, or a safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A59 | (A17 | A18))",
              "prover9_expression": "(supply_shortage(drug_x) | (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
              "natural": "Drug X has a supply shortage, or a safety profile for drug X is established, or efficacy of drug X is demonstrated."
            },
            {
              "id": "Fact9",
              "prover9": "-A59",
              "prover9_expression": "-supply_shortage(drug_x)",
              "natural": "It is not the case that drug X has a supply shortage."
            }
          ],
          "conclusion": "(A17 | A18)",
          "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A17 | A18)",
              "prover9_expression": "(safety_profile_established(drug_x) | efficacy_demonstrated(drug_x))",
              "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
            },
            {
              "id": "Rule7",
              "prover9": "(A17 -> (A15 | A16))",
              "prover9_expression": "(safety_profile_established(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
              "natural": "Should a safety profile for drug X be established, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
            },
            {
              "id": "Rule8",
              "prover9": "(A18 -> (A15 | A16))",
              "prover9_expression": "(efficacy_demonstrated(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
              "natural": "Assuming efficacy of drug X is demonstrated, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
            }
          ],
          "conclusion": "(A15 | A16)",
          "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule5",
              "prover9": "(A15 -> A13)",
              "prover9_expression": "(animal_testing_complete(drug_x) -> phase1_complete(drug_x))",
              "natural": "If animal testing for drug X is complete, then phase 1 for drug X is complete."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A14)",
              "prover9_expression": "(preliminary_human_trials_complete(drug_x) -> phase2_complete(drug_x))",
              "natural": "In the event that preliminary human trials for drug X are complete, phase 2 for drug X is complete."
            },
            {
              "id": "Derived",
              "prover9": "(A15 | A16)",
              "prover9_expression": "(animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x))",
              "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
            }
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(phase1_complete(drug_x) | phase2_complete(drug_x))",
              "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
            },
            {
              "id": "Rule3",
              "prover9": "(A13 -> G)",
              "prover9_expression": "(phase1_complete(drug_x) -> safe_for_use(drug_x))",
              "natural": "Provided that phase 1 for drug X is complete, drug X is safe for use."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> G)",
              "prover9_expression": "(phase2_complete(drug_x) -> safe_for_use(drug_x))",
              "natural": "Whenever phase 2 for drug X is complete, drug X is safe for use."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    },
    {
      "id": 12,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule54",
              "prover9": "(A67 -> A66)",
              "prover9_expression": "(temperature_sensitive(drug_x) -> storage_requirements(drug_x))",
              "natural": "Whenever drug X is temperature sensitive, then drug X has storage requirements."
            },
            {
              "id": "Fact2",
              "prover9": "A67",
              "prover9_expression": "temperature_sensitive(drug_x)",
              "natural": "Drug X is temperature sensitive."
            }
          ],
          "conclusion": "A66",
          "natural": "Drug X has storage requirements."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule53",
              "prover9": "(A66 -> A65)",
              "prover9_expression": "(storage_requirements(drug_x) -> shelf_life_reduction(drug_x))",
              "natural": "If drug X has storage requirements, then the shelf life of drug X is reduced."
            },
            {
              "id": "Derived",
              "prover9": "A66",
              "prover9_expression": "storage_requirements(drug_x)",
              "natural": "Drug X has storage requirements."
            }
          ],
          "conclusion": "A65",
          "natural": "The shelf life of drug X is reduced."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule52",
              "prover9": "(A65 -> (A64 | -A19))",
              "prover9_expression": "(shelf_life_reduction(drug_x) -> (stability_issue(drug_x) | -market_withdrawal(drug_x)))",
              "natural": "In case the shelf life of drug X is reduced, then either drug X has a stability issue or it is not the case that drug X is withdrawn from the market."
            },
            {
              "id": "Derived",
              "prover9": "A65",
              "prover9_expression": "shelf_life_reduction(drug_x)",
              "natural": "The shelf life of drug X is reduced."
            }
          ],
          "conclusion": "(A64 | -A19)",
          "natural": "Drug X has a stability issue, or it is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A64 | -A19)",
              "prover9_expression": "(stability_issue(drug_x) | -market_withdrawal(drug_x))",
              "natural": "Drug X has a stability issue, or it is not the case that drug X is withdrawn from the market."
            },
            {
              "id": "Fact10",
              "prover9": "-A64",
              "prover9_expression": "-stability_issue(drug_x)",
              "natural": "It is not the case that drug X has a stability issue."
            }
          ],
          "conclusion": "-A19",
          "natural": "It is not the case that drug X is withdrawn from the market."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule9",
              "prover9": "(A19 | (A17 | A18))",
              "prover9_expression": "(market_withdrawal(drug_x) | (safety_profile_established(drug_x) | efficacy_demonstrated(drug_x)))",
              "natural": "Drug X is withdrawn from the market, or a safety profile for drug X is established, or efficacy of drug X is demonstrated."
            },
            {
              "id": "Derived",
              "prover9": "-A19",
              "prover9_expression": "-market_withdrawal(drug_x)",
              "natural": "It is not the case that drug X is withdrawn from the market."
            }
          ],
          "conclusion": "(A17 | A18)",
          "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A17 | A18)",
              "prover9_expression": "(safety_profile_established(drug_x) | efficacy_demonstrated(drug_x))",
              "natural": "A safety profile for drug X is established, or efficacy of drug X is demonstrated."
            },
            {
              "id": "Rule7",
              "prover9": "(A17 -> (A15 | A16))",
              "prover9_expression": "(safety_profile_established(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
              "natural": "Should a safety profile for drug X be established, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
            },
            {
              "id": "Rule8",
              "prover9": "(A18 -> (A15 | A16))",
              "prover9_expression": "(efficacy_demonstrated(drug_x) -> (animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x)))",
              "natural": "Assuming efficacy of drug X is demonstrated, then either animal testing for drug X is complete or preliminary human trials for drug X are complete."
            }
          ],
          "conclusion": "(A15 | A16)",
          "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
        },
        {
          "step_number": 7,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule5",
              "prover9": "(A15 -> A13)",
              "prover9_expression": "(animal_testing_complete(drug_x) -> phase1_complete(drug_x))",
              "natural": "If animal testing for drug X is complete, then phase 1 for drug X is complete."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A14)",
              "prover9_expression": "(preliminary_human_trials_complete(drug_x) -> phase2_complete(drug_x))",
              "natural": "In the event that preliminary human trials for drug X are complete, phase 2 for drug X is complete."
            },
            {
              "id": "Derived",
              "prover9": "(A15 | A16)",
              "prover9_expression": "(animal_testing_complete(drug_x) | preliminary_human_trials_complete(drug_x))",
              "natural": "Animal testing for drug X is complete, or preliminary human trials for drug X are complete."
            }
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
        },
        {
          "step_number": 8,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(phase1_complete(drug_x) | phase2_complete(drug_x))",
              "natural": "Either phase 1 for drug X is complete, or phase 2 for drug X is complete."
            },
            {
              "id": "Rule3",
              "prover9": "(A13 -> G)",
              "prover9_expression": "(phase1_complete(drug_x) -> safe_for_use(drug_x))",
              "natural": "Provided that phase 1 for drug X is complete, drug X is safe for use."
            },
            {
              "id": "Rule4",
              "prover9": "(A14 -> G)",
              "prover9_expression": "(phase2_complete(drug_x) -> safe_for_use(drug_x))",
              "natural": "Whenever phase 2 for drug X is complete, drug X is safe for use."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is safe for use."
        }
      ]
    }
  ]
}